Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 11, 193

Evaluation of Health Related Quality of Life in Children With Immune Thrombocytopenia With the PedsQL™ 4.0 Generic Core Scales: A Study on Behalf of the Pays De Loire Pediatric Hematology Network

Affiliations

Evaluation of Health Related Quality of Life in Children With Immune Thrombocytopenia With the PedsQL™ 4.0 Generic Core Scales: A Study on Behalf of the Pays De Loire Pediatric Hematology Network

Marion Strullu et al. Health Qual Life Outcomes.

Abstract

Background: Immune thrombocytopenia (ITP) is a childhood disorder that is often life-altering for children and their parents. Health related quality of life (HRQL) has never been chronologically monitored in children with ITP. We initiated a prospective study to assess HRQL from diagnosis to six months and define factors that influence this outcome in children with ITP.

Methods: 73 children with acute ITP aged from 2 to 18 years were prospectively enrolled in the study. According to the presence of bleeding, they were or were not given a 4-day course of corticosteroid treatment. The PedsQL™ 4.0 Generic Core Scale was completed by children and parents upon their inclusion in the study and 6 months after diagnosis.

Results: Over the six month period, quality of life improved in terms of their global, physical and psychosocial well-being for 54.5%, 35.6% and 36.2% of patients respectively. This improvement is clinically relevant compared to scores at diagnosis, corresponding at least to a minimal clinically important difference (MCID). Factors such as sex, age, platelet count, bleeding scores, bone marrow aspiration and persistence of ITP at 6 months were not significantly associated with HRQL scores. However, preceding viral infection was identified to have an impact on HRQL.

Conclusions: This first longitudinal study assessing HRQL in children with ITP reveals a global improvement in PedSQL™ 4.0. However, these results should be considered with caution since our data also confirm that self-report HRQL scores are not influenced by any analyzed biologic or clinical parameters. Others tools, such as Kids' ITP Tools, would probably be required to assess the HRQL of this population.

Trial registration: Trial registration clinical trials.gov Identifier: NCT00331357.

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol. 1999;105(4):871–875. doi: 10.1111/j.1365-2141.1999.01409.x. - DOI - PubMed
    1. Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, Fryzek J, Kaye JA. Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol. 2010;149(6):855–864. doi: 10.1111/j.1365-2141.2010.08176.x. - DOI - PubMed
    1. Butros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol. 2003;25(8):660–664. doi: 10.1097/00043426-200308000-00017. - DOI - PubMed
    1. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld EJ, Vesely SK, Adix L, Blanchette VS, Kuhne T. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008;112(10):4003–4008. doi: 10.1182/blood-2008-03-138487. - DOI - PMC - PubMed
    1. Rodeghiero F. Idiopathic thrombocytopenic purpura: an old disease revisited in the era of evidence-based medicine. Haematologica. 2003;88(10):1081–1087. - PubMed

Publication types

Associated data

Feedback